首页> 外国专利> CRS Fragmented cysteinyl-tRNA synthetase peptide and use thereof

CRS Fragmented cysteinyl-tRNA synthetase peptide and use thereof

机译:CRS片段化的半胱氨酸-tRNA合成酶肽及其用途

摘要

The present invention relates to a fragmented CRS peptide and a use thereof, and more particularly, to a peptide comprising the amino acid sequence of SEQ ID NO: 2; A peptide comprising an amino acid sequence showing at least 80% homology with the peptide; A polynucleotide encoding the peptide; A vector containing the polynucleotide; Host cells transformed with the vector; And to their use as vaccine adjuvants. The peptide disclosed in the present invention is a CRS fragment first disclosed in the present specification and exhibits anticancer activity and immune function enhancing activity. In addition, the peptide, the polynucleotide encoding the same, the vector containing the polynucleotide, the host cell transformed with the vector, or the CRS full-length protein are excellent in anticancer activity and immune function enhancement activity, so that vaccine adjuvants, vaccine compositions and cancer It can be very usefully used in the development of therapeutic compositions.
机译:本发明涉及片段化的CRS肽及其用途,更特别地,涉及包含SEQ ID NO:2的氨基酸序列的肽。一种肽,其包含与该肽显示至少80%同源性的氨基酸序列;编码肽的多核苷酸;含有多核苷酸的载体;用载体转化的宿主细胞;并将其用作疫苗佐剂。本发明中公开的肽是本说明书中首先公开的CRS片段,并显示出抗癌活性和免疫功能增强活性。此外,该肽,编码该多核苷酸的多核苷酸,含有该多核苷酸的载体,经该载体转化的宿主细胞或CRS全长蛋白在抗癌活性和免疫功能增强活性方面均优异,因此疫苗佐剂,疫苗组合物和癌症在治疗组合物的开发中可以非常有用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号